用重组组织型纤溶酶原激活剂治疗的早产新生儿肺动脉血栓。
Pulmonary artery thrombus in a premature neonate treated with recombinant tissue plasminogen activator.
作者信息
DeMeo S D, Sherwood A, Hornik C D, Goldberg R N, Cotten C M, Bidegain M
机构信息
Division of Neonatology, Duke University Medical Center, Durham, NC, USA.
Division of Neonatology, University of North Carolina, Chapel Hill, NC, USA.
出版信息
J Perinatol. 2014 Jul;34(7):569-71. doi: 10.1038/jp.2014.34.
Pulmonary artery thrombus is a rarely reported complication in premature neonates. The management of life-threatening thrombotic events in neonates is controversial, especially regarding the use of thrombolytics versus anticoagulation alone for treatment. We report a case of a premature neonate with symptomatic pulmonary artery thrombus treated with recombinant tissue plasminogen activator who survived without bleeding complications.
肺动脉血栓是早产儿中鲜有报道的一种并发症。新生儿危及生命的血栓事件的治疗存在争议，尤其是在使用溶栓药物与单纯抗凝治疗方面。我们报告了一例有症状的肺动脉血栓早产儿，使用重组组织型纤溶酶原激活剂进行治疗，患儿存活且无出血并发症。
Zotero 插件